Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,974,797
-
Share change
-
+508,538
-
Total reported value
-
$12,730,680
-
Put/Call ratio
-
178%
-
Price per share
-
$3.20
-
Number of holders
-
48
-
Value change
-
+$1,583,226
-
Number of buys
-
15
-
Number of sells
-
18
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q2 2018
As of 30 Jun 2018,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,974,797 shares.
The largest 10 holders included
VANGUARD GROUP INC, DekaBank Deutsche Girozentrale, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Leisure Capital Management, BARD ASSOCIATES INC, NORTHERN TRUST CORP, MORGAN STANLEY, BANK OF MONTREAL /CAN/, and Walleye Trading LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.